Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.56
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
12.62
+0.06 (0.48%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Benitec Biopharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 184.76 | 97.74 | 50.87 | 2.48 | 4.06 | 19.77 |
Cash & Short-Term Investments | 184.76 | 97.74 | 50.87 | 2.48 | 4.06 | 19.77 |
Cash Growth | 78.37% | 92.16% | 1953.53% | -39.02% | -79.45% | 101.68% |
Accounts Receivable | - | - | - | 0.06 | 0 | 0.03 |
Other Receivables | 0 | 0.03 | 0.23 | - | - | - |
Receivables | 0 | 0.03 | 0.23 | 0.06 | 0 | 0.03 |
Prepaid Expenses | 1.14 | 0.63 | 0.52 | 1.18 | 0.74 | 0.8 |
Restricted Cash | 0.11 | 0.11 | 0.06 | 0.01 | 0.01 | 0.02 |
Total Current Assets | 186.02 | 98.52 | 51.67 | 3.73 | 4.82 | 20.61 |
Property, Plant & Equipment | 0.92 | 0.99 | 0.45 | 0.61 | 0.99 | 0.58 |
Other Long-Term Assets | 0.07 | 0.08 | 0.09 | 0.12 | 0.16 | 0.19 |
Total Assets | 187 | 99.59 | 52.21 | 4.46 | 5.97 | 21.38 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.64 | 0.2 | 1.35 | 1.14 | 0.42 | 0.27 |
Accrued Expenses | 0.69 | 0.52 | 0.65 | 0.74 | 0.7 | 0.49 |
Current Portion of Leases | 0.48 | 0.35 | 0.28 | 0.28 | 0.25 | 0.21 |
Other Current Liabilities | 1.47 | 0.72 | 2.64 | 1.82 | 1.16 | 0.39 |
Total Current Liabilities | 3.27 | 1.8 | 4.92 | 3.98 | 2.53 | 1.37 |
Long-Term Leases | 0.39 | 0.5 | - | 0.28 | 0.56 | - |
Pension & Post-Retirement Benefits | - | - | 0.04 | - | - | - |
Total Liabilities | 3.67 | 2.3 | 4.96 | 4.26 | 3.09 | 1.37 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 0 | 0 | 0 | - | - | 0 |
Additional Paid-In Capital | 445.19 | 326.31 | 238.4 | 168.92 | 152.45 | 151.58 |
Retained Earnings | -260.91 | -228.18 | -190.26 | -167.89 | -148.33 | -130.12 |
Comprehensive Income & Other | -0.95 | -0.84 | -0.89 | -0.83 | -1.25 | -1.46 |
Shareholders' Equity | 183.33 | 97.3 | 47.25 | 0.2 | 2.88 | 20.01 |
Total Liabilities & Equity | 187 | 99.59 | 52.21 | 4.46 | 5.97 | 21.38 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.88 | 0.85 | 0.28 | 0.56 | 0.81 | 0.21 |
Net Cash (Debt) | 183.89 | 96.9 | 50.58 | 1.92 | 3.25 | 19.56 |
Net Cash Growth | 79.18% | 91.56% | 2537.23% | -41.00% | -83.38% | 108.11% |
Net Cash Per Share | 4.13 | 2.68 | 2.75 | 1.38 | 6.76 | 77.40 |
Filing Date Shares Outstanding | 34.35 | 26.25 | 10.56 | 2.55 | 0.48 | 0.48 |
Total Common Shares Outstanding | 34.35 | 26.25 | 10.09 | 1.65 | 0.48 | 0.48 |
Working Capital | 182.74 | 96.72 | 46.75 | -0.25 | 2.29 | 19.24 |
Book Value Per Share | 5.34 | 3.71 | 4.68 | 0.12 | 6.00 | 41.63 |
Tangible Book Value | 183.33 | 97.3 | 47.25 | 0.2 | 2.88 | 20.01 |
Tangible Book Value Per Share | 5.34 | 3.71 | 4.68 | 0.12 | 6.00 | 41.63 |
Machinery | 1.37 | 1.57 | 1.55 | 1.38 | 1.37 | 1.36 |
Leasehold Improvements | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |